A Comprehensive Analysis of Key Idiopathic Pulmonary Fibrosis Treatment Market Players and Their Impact on Revenue Growth
The global Idiopathic Pulmonary Fibrosis (IDF) treatment market size was USD 3.51 Billion in 2022 and is expected to register a rapid revenue CAGR of 6.2% during the forecast period. Increasing Research & Development (R&D) activities and rapid technological advancements in pulmonary fibrosis are key factors driving market revenue growth.
Emergen Research has published a research report...
0 Σχόλια
0 Μοιράστηκε
232 Views
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Tiếng Việt